United States · FDA National Drug Code directory
Sumatriptan Succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-141_4bbdfb46-6291-2fa4-948a-b505c0eea287
- Product NDC
- 72603-141
- Form
- INJECTION
- Composition / generic term
- Sumatriptan Succinate
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230613
- Source listing expiry
- 20271231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 6 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (72603-141-02) / .5 mL in 1 SYRINGE (72603-141-01) · 72603-141-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →